The new phase of China’s economic with GDP over 10 Trillion USD in 2015, requires a balanced development. Besides others, healthcare is one of the most important sector needs to be improved. Does the new regulation create difficulties or opportunities for Swiss and European companies? How to step in China for investment or expansion your life science related business under the current economic situation?
On Thursday Morning, April 21st, 2016, at Swissôtel in Basel,
the country and industry experts will give you a very good understanding with a focus on the Chinese current regulatory reform and the MedTech & pharmaceutical product registration, as well as the experience of successfully launched a Swiss pharma product into China’s Market.
Zhongshan is located in Guangdong Province, next to Hongkong. The advantageous geographic location has created a favorable business and investment environment, especially for the healthcare industry.
This event is for senior executives and project leaders of life science related Swiss and European companies. Participants will have the opportunity to meet healthcare specialists for China’s Market, Swiss MedTech and pharma industry representatives.
A great opportunity to get deep view about the existing situation of China’s economic, the impact to healthcare industry, theory and practical experience.
Please register before April 15, 2016 via link http://zhongshan-overseas-forum-basel.evenium.net. If you have questions, please contact us by info(at)zhongshan.ch
The event will be held in English with simultaneous translation into Chinese. There is no cost to attend but attendance is limited.